Journal: Drug Delivery and Translational Research
Article Title: Evaluation of the clinical impact of repeat application of hydrogel-forming microneedle array patches
doi: 10.1007/s13346-020-00727-2
Figure Lengend Snippet: I : levels of plasma CRP at the beginning and the end of the study, as determined using ELISA (means ± SE, n = 11) (A) and individual volunteer values (B). II : levels of plasma IgG at the beginning and the end of the study, as determined using ELISA (means ± SE, n = 11) (A) and individual volunteer values (B). III : levels of plasma IgE at the beginning and the end of the study, as determined using ELISA (means ± SE, n = 11) (A) and individual volunteer values (B). IV : levels of plasma TNF-α at the beginning and the end of the study, as determined using ELISA (means ± SE, n = 11) (A) and individual volunteer values (B). ns, non-significant
Article Snippet: Commercially available enzyme-linked immunosorbent assay (ELISA) kits were used (Human total IgG Platinum ELISA quantification kit, Affymetrix, Austria; Human IgE Platinum ELISA quantification kit, Affymetrix, Austria; Human CRP instant ELISA quantification kit, eBioscience, Austria; Human TNF-α ultrasensitive ELISA quantification kit, Invitrogen Corporation, USA; Human IL-1β Platinum ELISA quantification kit, Affymetix, Austria), according to the manufacturers’ instructions.
Techniques: Enzyme-linked Immunosorbent Assay